Diabetes and chronic kidney disease: Lessons from renal epidemiology

被引:9
|
作者
Villar, Emmanuel [1 ]
Zaoui, Philippe [2 ]
机构
[1] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Serv Nephrol Dialyse & Transplantat Renale, F-69495 Pierre Benite, France
[2] CHU Grenoble, Serv Nephrol Transplantat Renale, F-38043 Grenoble, France
来源
NEPHROLOGIE & THERAPEUTIQUE | 2010年 / 6卷 / 07期
关键词
Chronic kidney disease; Diabetic nephropathy; Epidemiology; End-stage renal disease; Gender; Incidence; Prevalence; Type; 1; diabetes; 2; Survival; REPLACEMENT THERAPY; GLYCEMIC CONTROL; RISK-FACTORS; IMPROVED SURVIVAL; MAINLAND FRANCE; WAITING-LIST; NEW-ZEALAND; FOLLOW-UP; STAGE; NEPHROPATHY;
D O I
10.1016/j.nephro.2010.08.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In industrialized countries, renal epidemiology is faced with the growing epidemic of diabetes as cause of renal involvement or as an associated condition. In France, recent studies estimate that 400 000+ diabetics have a glomerular filtration rate lower than 60 mL/min/1.73 m(2), and that 7000+ are prevalent in dialysis. The vast majority has type 2 diabetes. In type 1 diabetes, renal prognosis improved over the last decade due to available aggressive glycemic control and treatment with renin-angiotensin system inhibitors. Diabetes has a negative impact on survival in end-stage renal disease, particularly for type 1 diabetes patients and for women with diabetes. In type 2 diabetes, improvement in early access to renal transplant could lead to improvement in outcomes, whereas they are usually contra-indicated for transplant because rapid decline in cardiovascular status on dialysis. All these epidemiological data help us to implement preventing measures and further researches in order to improve diabetes patient prognosis. (C) 2010 Association Societe de nephrologie. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 50 条
  • [21] Epidemiology of dyslipidemia in chronic kidney disease
    Kunitoshi Iseki
    Clinical and Experimental Nephrology, 2014, 18 : 185 - 188
  • [22] Epidemiology of obesity and chronic kidney disease
    Ross, Will R.
    McGill, Janet B.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2006, 13 (04) : 325 - 335
  • [23] Epidemiology of chronic kidney disease and anemia
    Robinson, Bruce E.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2006, 7 (09) : S3 - S6
  • [24] Epidemiology, geography and chronic kidney disease
    McClellan, Ann C.
    Plantinga, Laura
    McClellan, William M.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (03): : 323 - 328
  • [25] Linking the population epidemiology of acute renal failure, chronic kidney disease and end-stage renal disease
    Hsu, Chi-yuan
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2007, 16 (03): : 221 - 226
  • [26] Epidemiology of hyperkalemia in chronic kidney disease
    Belmar Vega, Lara
    Rodrigo Galabia, Emilio
    Bada da Silva, Jairo
    Bentanachs Gonzalez, Marta
    Fernandez Fresnedo, Gema
    Pinera Haces, Celestino
    Palomar Fontanet, Rosa
    Ruiz San Millan, Juan Carlos
    Martin de Francisco, Angel Luis
    NEFROLOGIA, 2019, 39 (03): : 277 - 286
  • [27] Genetic epidemiology of chronic kidney disease
    Estrella, Michelle M.
    Sperati, Chistopher J.
    Kao, Wen H. L.
    Parekh, Rulan S.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (03): : 283 - 291
  • [28] Epidemiology of pediatric chronic kidney disease
    Harambat, Jerome
    Madden, Iona
    Hogan, Julien
    NEPHROLOGIE & THERAPEUTIQUE, 2021, 17 (06): : 476 - 484
  • [29] Epidemiology of dyslipidemia in chronic kidney disease
    Iseki, Kunitoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) : 185 - 188
  • [30] Epidemiology of chronic kidney disease in children
    Jérôme Harambat
    Karlijn J. van Stralen
    Jon Jin Kim
    E. Jane Tizard
    Pediatric Nephrology, 2012, 27 : 363 - 373